Invention Grant
- Patent Title: In vitro release testing (IVRT) device for orally inhaled drug products
-
Application No.: US17776670Application Date: 2019-11-15
-
Publication No.: US12078628B2Publication Date: 2024-09-03
- Inventor: Robert Price , Arron Danson , Gregor Strni{hacek over (s)}a
- Applicant: NANOPHARM LIMITED
- Applicant Address: GB Newport
- Assignee: NANOPHARM LIMITED
- Current Assignee: NANOPHARM LIMITED
- Current Assignee Address: GB Newport
- Agency: Sughrue Mion, PLLC
- International Application: PCT/EP2019/081551 2019.11.15
- International Announcement: WO2021/093979A 2021.05.20
- Date entered country: 2022-05-13
- Main IPC: G01N33/15
- IPC: G01N33/15 ; B01D63/08 ; B01D69/10

Abstract:
An in vitro release testing (IVRT) device for orally inhaled drug products, for use in an IVRT apparatus, the device having an air-permeable filter loaded with particulate material representing a dose of an orally inhaled drug product. The device has an upper filter support element and a lower filter support element, the loaded filter being circumferentially retained between the upper and lower support elements, a filter cover to cover the upper surface of the loaded filter, and a filter cover retainer provided to assemble and seal the IVRT device.
Public/Granted literature
- US20220404326A1 IN VITRO RELEASE TESTING (IVRT) DEVICE FOR ORALLY INHALED DRUG PRODUCTS Public/Granted day:2022-12-22
Information query